InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. is a Healthcare & Life Sciences startup based in the United States, since acquired, 1 tracked investor.
About InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. is a company headquartered in the United States. InflammX Therapeutics, Inc. has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
InflammX Therapeutics develops orally administered compounds that inhibit the dysregulated inflammasome pathway of autoinflammation by normalizing prematurely open pathological hemichannels, targeting diseases such as diabetic macular edema, macular degeneration, and chronic kidney diseases.
Explore InflammX Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.